SUN PHARMACEUTICAL INDUSTRIES LIMITED II
SUN PHARMACEUTICAL INDUSTRIES LIMITED II |
|
CERTIFICAÇÃO: Anexo à Resolução RE nº 4.364, de 16 de novembro de 2023
|
|
HISTORY |
|
RESPONSÁVEIS RESPONSIBLE POSITIONS |
|
COORDENADOR DO CENTRO: BIOEQUIVALENCE CENTRE CO-ORDINATOR: |
Dr. Arshad H. Khuroo |
RESPONSÁVEL PELA GARANTIA DA QUALIDADE: QUALITY ASSURANCE MANAGER: |
Ms. Ivy Janakiraman |
RESPONSÁVEL PELA ETAPA CLÍNICA: HEAD CLINICAL PHARMACOLOGY DEPARTMENT: |
Dr. Sachin Mehra |
RESPONSÁVEL PELAS ANÁLISES ESTATÍSTICAS: RESPONSIBLE FOR BIOSTATISTICAL ANALYSIS: |
Dr. Sudershan Kumar |
RESPONSÁVEL PELA ETAPA BIOANALÍTICA: HEAD BIOANALYTICAL DEPARTMENT: |
Dr. Sanjay Jagannath Gurule |
SEDE DO CENTRO DE BIOEQUIVALÊNCIA BIOEQUIVALENCE HEADQUARTER |
|
Endereço (ADDRESS): Research & Development Centre, Sarhaul, Sector-18, Gurgaon Haryana - India |
|
ETAPA CLÍNICA CLINICAL PHARMACOLOGY DEPARTMENT Número de leitos (# OF BEDS): 84 |
|
UNIDADE CLÍNICA DE INTERNAÇÃO (CLINIC HOSPITALIZATION UNIT): Sun Pharmaceutical Ltd Industries Clinical Pharmacology Unit (84 leitos/beds) Endereço (ADDRESS): II Floor; Hakeen Abdul Hameed Centenary Hospital, Hamdard Nagar - New Delhi - India Tel/Fax (PHONE/FAX): 91-11-2995-8529, 2995-6721/91-11-2605-9879 |
|
ETAPA BIOANALÍTICA BIOANALYTICAL DEPARTMENT |
|
Endereço (ADDRESS): Vill. Sarhaul, Sector-18, Gurugram, Gurgaon Haryana - India |